Since Dex exposure activates PLCγ2 signaling pathway, we aimed to determine whether PLCγ2 inhibition could enhance Dex sensitivity and reverse Dex resistance in B-ALL cells. Here, PLCG2 is linked to acute lymphoblastic leukemia.